In the fall of last year, I believed that the risk-reward proposition for Inspire Medical (INSP) was improving after shares were lagging, the business became profitable and the FDA granted approval ...

Inspire Medical Systems has appointed Matt Osberg as Executive Vice President and Chief Financial Officer, effective January ...

Inspire Medical Systems is a rapidly growing medical technology company specializing in a device that treats Obstructive Sleep Apnea. The company is still in the early stages of developing their ...

Inspire Medical Systems, Inc. (NYSE:INSP) ranks among the best medical device stocks to invest in. On October 10, Inspire Medical Systems, Inc. (NYSE:INSP) published clinical data demonstrating the ...

The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of its ...

Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or CPAP, machines are the standard treatment. However, they can be loud, uncomfortable and have a pesky ...

Inspire Medical Systems INSP is preparing to release its quarterly earnings on Monday, 2025-05-05. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...

Inspire Medical Systems appoints Dr. Paul Hoff and Dr. Ruchir Patel as Vice President, Senior Medical Directors to enhance OSA treatment. Inspire Medical Systems, Inc. announced the appointment of two ...

Revenue for full year 2025 is anticipated to be in the range of $940 million to $955 million, a 17% to 19% increase over full year 2024 “We are very pleased with our strong preliminary revenue ...

Belgium-based medical technology company Nyxoah, which specializes in alternative treatments for obstructive sleep apnea, has filed a patent infringement lawsuit against Inspire Medical Systems. The ...